Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
23 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/23/2951248/0/en/Invivyd-Provides-Detailed-Virology-Data-and-Analysis-of-SARS-CoV-2-Structural-Biology-Predicting-Anticipated-Neutralization-Activity-for-PEMGARDA-pemivibart.html
12 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/12/2945073/0/en/Invivyd-at-the-Ready-for-Upcoming-Respiratory-Virus-Season-with-PEMGARDA-pemivibart-to-Help-Protect-Vulnerable-Immunocompromised-Persons-from-COVID-19.html
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/05/2941219/0/en/Invivyd-to-Participate-in-Upcoming-Investor-Conferences.html
04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940365/0/en/Invivyd-Doses-First-Participants-in-Phase-1-Clinical-Trial-of-VYD2311-a-Next-Generation-Monoclonal-Antibody-Candidate-for-COVID-19-Building-on-the-Success-of-PEMGARDA.html
03 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/03/2939541/0/en/Invivyd-Announces-Continued-Neutralizing-Activity-of-PEMGARDA-pemivibart-Against-Dominant-SARS-CoV-2-Variants-KP-3-1-1-and-LB-1-and-Other-Variants-of-Interest.html
28 Aug 2024
// ENDPTS
https://endpts.com/invivyd-says-new-phase-3-data-on-covid-antibody-support-prophylactic-use/
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?